跳至主要内容
临床试验/NCT06355622
NCT06355622招募中不适用

Pain in RASopathies: New Investigative Techniques and Possible Treatments

Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年1月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
Prevalence of pain in verbal patients with RASopathies

研究概览

简要总结

RASopathies are a group of syndromes caused by variants in genes belonging to the RAS/MAPK pathway. Pain is a neglected topic in RASopathies but it is frequently complained by affected individuals.

详细描述

To detect prevalence and characteristics of pain in RASopathies by using scales, questionnaires, biochemical analysis and neurophysiological assessment tests.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • All individuals with clinical and molecularly confirmed diagnosis of a RASopathy

排除标准

  • Individuals with a RASopathy con confirmed by genetic analysis

结局指标

主要结局

Prevalence of pain in verbal patients with RASopathies

时间窗: 2 years

To detect the prevalence of pain in verbal patients with RASopathies by using VAS (visual analogue scale) or NRS (numeric rating sclae). Both scales include a range from 0 to 10 where 0 represents no pain, 1-3 range represents mild pain, 4-6 range represents moderate pain and 7-10 range represents severe pain.

Prevalence of Pain in no-communitating patients with RASopathies

时间窗: 2 years

To detect the prevalence of pain in no-communicating patients with RASopathies by using FLACC scale. The FLACC Scale includes 5 behavioral categories: facial expression, leg movement, bodily activity, cry or verbalization, and consolability. The parents rated their child's pain at its worst within the preceding 24 h in each category on a scale of 0 to 2, thus an overall pain score ranging from 0 to 10.

次要结局

  • Characterization of pain in RASopathies(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验